Skip to main content

Table 1 Comparison of clinical variables between non-cachexia and cachexia patients

From: Plasma concentration of interleukin-6 was upregulated in cancer cachexia patients and was positively correlated with plasma free fatty acid in female patients

 Non-cachexia (n = 237)Cachexia (n = 74)t/x2p
Ages (years)62.34 ± 0.7364.14 ± 1.191.2260.221
Female no. (%)87 (36.7%)24 (32.4%)0.4490.503
BMI (kg/m2)22.91 ± 0.1922.08 ± 0.382.0360.043
HB (g/L)119.5 ± 1.68111.8 ± 3.022.2270.027
WBC (10^9/L)5.72 ± 0.116.07 ± 0.251.4220.156
PLT (10^9/L)237.9 ± 5.15262.9 ± 11.752.2110.028
LY (10^9/L)1.64 ± 0.041.40 ± 0.053.1680.002
TP (g/L)65.36 ± 0.4163.64 ± 0.782.0160.045
ALB (g/L)40.88 ± 0.3239.15 ± 0.562.6750.008
PA (g/L)0.214 ± 0.0040.189 ± 0.0063.525<0.001
TC (mmol/L)4.19 ± 0.073.91 ± 0.092.1490.033
TG (mmol/L)1.32 ± 0.041.17 ± 0.061.9020.058
ApoA (g/l)176.8 ± 12.62220.1 ± 23.611.6770.095
ApoB (g/l)0.873 ± 0.0170.852 ± 0.0290.6040.547
ApoE (g/l)41.55 ± 0.8236.78 ± 1.362.9190.004
FFA (pg/ml)0.42 ± 0.020.48 ± 0.032.0220.044
IL-6 (pg/ml)4.88 ± 0.288.16 ± 0.984.429<0.001
TNF-α (pg/ml)7.45 ± 0.238.09 ± 0.371.3980.164
(I + II) TNM stage no. (%)125 (52.7%)24 (32.4%)9.3210.002
  1. BMI Body mass index, HB Hemoglobin, WBC White blood cell count, PLT Platelet, LY Lymphocyte count, TP Total protein, ALB Albumin, PA Prealbumin, TC Total cholesterol, TG Tri-glyceride, ApoA Apolipoprotein A, ApoB Apolipoprotein B, ApoE Apolipoprotein E, FFA Free fatty acid